Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy


Author index

Page Path
HOME > Browse Articles > Author index
Bassel El-Rayes 1 Article
Epidemiology of early esophageal adenocarcinoma
Thuy-Van P. Hang, Zachary Spiritos, Anthony M. Gamboa, Zhengjia Chen, Seth Force, Vaishali Patel, Saurabh Chawla, Steven Keilin, Nabil F. Saba, Bassel El-Rayes, Qiang Cai, Field F. Willingham
Clin Endosc 2022;55(3):372-380.   Published online February 11, 2022
AbstractAbstract PDFPubReaderePub
/Aims: Endoscopic resection has become the preferred treatment approach for select early esophageal adenocarcinoma (EAC); however, the epidemiology of early stage disease has not been well defined.
Surveillance Epidemiology and End Results (SEER) data were analyzed to determine age-adjusted incidence rates among major epithelial carcinomas, including EAC, from 1973 to 2017. The percent change in incidence over time was compared according to tumor subtype. Early T-stage, node-negative EAC without metastasis was examined from 2004 to 2017 when precise T-stage data were available.
The percent change in annual incidence from 1973 to 2017 was 767% for EAC. Joinpoint analysis showed that the average annual percent change in EAC from 1973 to 2017 was 5.11% (95% confidence interval, 4.66%–5.56%). The annual percent change appeared to plateau between 2004 and 2017; however, early EAC decreased from 2010 to 2017, with an annual percent change of -5.78%.
There has been a 7-fold increase in the incidence of EAC, which was significantly greater than that of the other major epithelial malignancies examined. More recently, the incidence of early EAC has been decreasing. Approximately one in five patients has node negative, potentially resectable early stage disease.


Citations to this article as recorded by  
  • Concise Commentary: It’s All Downhill from Here—How Diagnostic and Therapeutic Advances May Decrease the Incidence Rates of Gastroesophageal Junction and Esophageal Adenocarcinoma
    Anthony Gamboa, Rishi Naik
    Digestive Diseases and Sciences.2024; 69(1): 254.     CrossRef
  • Descriptive Epidemiology of Early-Onset Gastrointestinal Cancers in Iran, 2014-2018
    Mohammad Sadra Gholami Chahkand, Fatemeh Esmaeilpour Moallem, Fatemeh Ghasemi-Kebria, Reza Malekzadeh, Gholamreza Roshandel, Mohammad Taher
    Middle East Journal of Digestive Diseases.2024; 16(1): 28.     CrossRef
  • Epidemiologie der Adenokarzinome des Ösophagus und des ösophagogastralen Übergangs
    Sabine Luttmann, Andrea Eberle, Joachim Hübner
    Die Onkologie.2023; 29(6): 470.     CrossRef
  • Evaluation of Esophageal Dysphagia in Elderly Patients
    Khanh Hoang Nicholas Le, Eric E. Low, Rena Yadlapati
    Current Gastroenterology Reports.2023; 25(7): 146.     CrossRef
  • Histology Shift in Esophageal Cancer Between Biopsies and Resections After Neoadjuvant Therapy: A Pilot Study
    Tieying Hou, Zhaohai Yang, Qingzhao Zhang, Xuchen Zhang, Xiaoyan Liao, Jingmei Lin
    International Journal of Surgical Pathology.2023;[Epub]     CrossRef
  • Molecular Biology and Clinical Management of Esophageal Adenocarcinoma
    Shulin Li, Sanne Johanna Maria Hoefnagel, Kausilia Krishnawatie Krishnadath
    Cancers.2023; 15(22): 5410.     CrossRef
  • Progress in Clinical Management of Esophago-Jejunal Anastomotic Fistula with Total Gastrectomy for Adenocarcinoma of the Esophagogastric Junction
    天伟 赖
    Advances in Clinical Medicine.2023; 13(11): 17210.     CrossRef
  • Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model
    Yun Zhang, Katherine M. Weh, Bridget A. Tripp, Jennifer L. Clarke, Connor L. Howard, Shruthi Sunilkumar, Amy B. Howell, Laura A. Kresty
    Pharmaceuticals.2023; 16(12): 1697.     CrossRef
  • Lessons learned in clinical epidemiology of esophageal adenocarcinoma
    Hye Kyung Jung
    Clinical Endoscopy.2022; 55(3): 365.     CrossRef
  • 4,831 View
  • 268 Download
  • 5 Web of Science
  • 9 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer